GLG News by Plastic Surgeons who Preform Breast Reconstruction and Augmentation

Michael BainWound Care DirectorNewport Nursing and Rehabilitation

FDA issues safety signal on ALCL & breast implants

January 31, 2011

Analysis of:FDA issues safety signal on ALCL & breast implants | www.psnextra.org

http://www.psnextra.org/Articles/FDA-ACLC-Issue.htmlThere is a link between breast implants and anaplastic large cell lymphoma (ALCL).  This very rare tumor has almost no cases in the literature.  There appears that there might be an association between the two.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

A Low Cost EMR System From Wal-Mart?

March 16, 2009

Analysis of:Wal-Mart Plans to Market Digital Health Records System | www.nytimes.com

Wal-Mart is one of the top consumer retailers in the country.  They have already entered the world of competitive, low cost health care delivery with their $4.00 generic prescriptions and their Nurse Practitioner run clinics--so becoming a warehouse for state-of-the-art electronic medical records (EMR's) is a natural progression.  I see this as a great business move for Wal-Mart as they will combine their buying power with Dell's technology expertise, creating an affordable EMR system to revolutionize American medicine.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

Health Care in America--An Ailing Commodity That Doctors Can't Cure

January 30, 2009

Analysis of:Perspectives on Health Reform, 17th January 2009 | healthaffairs.org

Fixing the health care system in America is like trying to fix the economy.  We keep dumping more and more money into it, only to find ourselves going nowhere.  There seems to be a renewed sense of hope with the emergence of a new administration in Washington, but there are no easy solutions.  We are a country endeared to our ever increasingly expensive technology, which everyone wants, but only few can afford.  We treat everyone who needs medical care, whether or not they can afford it, taking the position that hospitals and doctors will absorb the cost.  Well, hospitals and yes doctors, are going out of business.  Until the actual issues are looked at and tough decisions are made, we will find ourselves in a situation of a government run, nationalized health care system (ala Canada) which will set medicine in America back to the stone ages.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

High End Medical Devices and Implants Are Not Immune to This Recession

January 22, 2009

Analysis of:Medical devices not immune to recession worries | www.boston.com

As America faces one of the worst recessions in history, all businesses suffer, including the health care industry.  With the steady rise of unemployment, more and more people are losing their jobs, and with it their health insurance.  This has a direct impact on medical device companies, as non-emergent surgical procedures and services are put off as long as possible, thus limiting the usage of their products.

Robert FrankOwnerAria Cosmetic and Reconstructive Surgery

Mentor/J&J deal is long overdue

December 3, 2008

Analysis of:Johnson & Johnson buys medical device maker | www.nytimes.com

The purchase of implant manufacturer, Mentor Corporation, by Johnson and Johnson will level the playing field as Mentor seeks to take market share from Allergan in both the breast implant business as well as facial fillers and competitors to Botox.

Adam SchaffnerDirector of Plastic SurgeryJUVA SKIN LASER CENTER INC

Bold Contest for a Daunting Problem

October 27, 2008

Analysis of:WellPoint, X Prize launch $10M health care contest | news.yahoo.com

Most people agree that the healthcare system in the United States is in need of a complete overhaul.  Unfortunately, the many competing interests in the current system make such overhaul extremely challenging.  This contest certainly provides much incentive for the best and brightest to put forth their ideas on how to improve the system.  Overcoming the obstacles to implenting such ideas will potentially be the biggest challenge of all.  Therefore, I believe the answer to the question "Will it work?" will only come when the healthcare system reaches the same critical threshold that our financial markets recently met.

Robert FrankOwnerAria Cosmetic and Reconstructive Surgery

Dermatologists? I worry more about the Family practitioners, Ob-Gyns, and Internists...

July 31, 2008

Analysis of:As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com

As insurance reimbursements decline, everyone suddenly thinks they're a cosmetic surgeon.

Adam SchaffnerDirector of Plastic SurgeryJUVA SKIN LASER CENTER INC

Evolence: Will this New "Advanced" Collagen Filler Take Hold?

July 8, 2008

Analysis of:FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com

Evolence is an injectable filler material that is made by an "advanced collagen GLYMATRIX™ Technology."  Collagen has generally fallen out of favor amongst aesthetic physicians due to its short duration of action.  Evolence will have to demonstrate that it is superior to the plethora of other injectable filler materials currently available to gain market share.  To do so will not only require clinical efficacy, it will also require a tremendous marketing effort to penetrate a market where there is no shortage of injectable filler materials from which to choose.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

And yet, another filler? Is this the Holy Grail?

July 8, 2008

Analysis of:FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com

Over the past few years, noninvasive cosmetic procedures have skyrocketed.  Soft tissue injectable fillers are among those procedures that are rapidly growing.  Up until now, hyaluronic acid (HA) fillers have been the mainstay.  With the emergence of Envolence, we have a new twist on an old product--collagen.  Since this does not involve skin testing and can be used at the same time as the patient's initial visit, this may prove to be an exciting new product, and may capture a fair share of the injectable filler market place.

Adam SchaffnerDirector of Plastic SurgeryJUVA SKIN LASER CENTER INC

Allergan and Aczone: Likely a Winning Combination

June 26, 2008

Analysis of:Allergan Aquisition of Aczone | agn360.client.shareholder.com

Allergan has a strong infrastructure to support dermatologic and aesthetic products.  Aczone, an aqueous topical gel containing 5% dapsone, will be a new product which will help treat patients with acne.  "The strength of topical dapsone gel appears to be its high efficacy against inflammatory acne lesions.  Both rapid onset of action and tolerability make this agent a potentially nice complement to traditional antimicrobial and comedolytic acne regimens." (Draelos ZD, Carter E, Maloney JM, et al, J Am Acad Dermatol. 2007;56:439.e1-e10.)  Based on the study results available, it appears Aczone will provide an additional treatment option which will benefit patients.  Given the number of patients afflicted with acne, I believe Allergan will ultimately view this as a favorable acquisition.

Page : 12345Next1 to 10 of 45